Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 29001 - 29025 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Dasatinib	Approved Investigational	CENPK	64105	downregulated	Dasatinib results in decreased expression of CENPK mRNA	5q12.3	A21899
Dasatinib	Approved Investigational	CENPL	91687	downregulated	Dasatinib results in decreased expression of CENPL mRNA	1q25.1	A21899
Dasatinib	Approved Investigational	CENPN	55839	downregulated	Dasatinib results in decreased expression of CENPN mRNA	16q23.2	A21899
Dasatinib	Approved Investigational	CENPO	79172	downregulated	Dasatinib results in decreased expression of CENPO mRNA	2p23.3	A21899
Dasatinib	Approved Investigational	CENPU	79682	downregulated	Dasatinib results in decreased expression of CENPU mRNA	4q35.1	A21899
Dasatinib	Approved Investigational	CENPW	387103	downregulated	Dasatinib results in decreased expression of CENPW mRNA	6q22.32	A21899
Dasatinib	Approved Investigational	CEP128	145508	downregulated	Dasatinib results in decreased expression of CEP128 mRNA	14q31.1	A21899
Dasatinib	Approved Investigational	CEP152	22995	downregulated	Dasatinib results in decreased expression of CEP152 mRNA	15q21.1	A21899
Dasatinib	Approved Investigational	CES1	1066	upregulated	Dasatinib results in increased expression of CES1 mRNA	16q12.2	A21899
Dasatinib	Approved Investigational	CHAC1	79094	upregulated	Dasatinib results in increased expression of CHAC1 mRNA	15q15.1	A21899
Dasatinib	Approved Investigational	CHI3L1	1116	upregulated	Dasatinib results in increased expression of CHI3L1 mRNA	1q32.1	A21899
Dasatinib	Approved Investigational	CKAP2L	150468	downregulated	Dasatinib results in decreased expression of CKAP2L mRNA	2q14.1	A21899
Dasatinib	Approved Investigational	CKS1B	1163	downregulated	Dasatinib results in decreased expression of CKS1B mRNA	1q21.3	A21899
Dasatinib	Approved Investigational	CKS2	1164	downregulated	Dasatinib results in decreased expression of CKS2 mRNA	9q22.2	A21899
Dasatinib	Approved Investigational	CLSPN	63967	downregulated	Dasatinib results in decreased expression of CLSPN mRNA	1p34.3	A21899
Dasatinib	Approved Investigational	CLU	1191	upregulated	Dasatinib results in increased expression of CLU mRNA	8p21.1	A21899
Dasatinib	Approved Investigational	CNN1	1264	upregulated	Dasatinib results in increased expression of CNN1 mRNA	19p13.2	A21899
Dasatinib	Approved Investigational	CNNM2	54805	upregulated	Dasatinib results in increased expression of CNNM2 mRNA	10q24.32	A21899
Dasatinib	Approved Investigational	COL11A1	1301	upregulated	Dasatinib results in increased expression of COL11A1 mRNA	1p21.1	A21899
Dasatinib	Approved Investigational	COL3A1	1281	upregulated	Dasatinib results in increased expression of COL3A1 mRNA	2q32.2	A21899
Dasatinib	Approved Investigational	COL4A1	1282	upregulated	Dasatinib results in increased expression of COL4A1 mRNA	13q34	A21899
Dasatinib	Approved Investigational	COL4A2	1284	upregulated	Dasatinib results in increased expression of COL4A2 mRNA	13q34	A21899
Dasatinib	Approved Investigational	CPA4	51200	downregulated	Dasatinib results in decreased expression of CPA4 mRNA	7q32.2	A21899
Dasatinib	Approved Investigational	CPQ	10404	upregulated	Dasatinib results in increased expression of CPQ mRNA	8q22.1	A21899
Dasatinib	Approved Investigational	CRISPLD2	83716	upregulated	Dasatinib results in increased expression of CRISPLD2 mRNA	16q24.1	A21899

Displaying entries 29001 - 29025 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability